HOXB5 and cancer: Our research found that HOXB5 inhibited the key genes CCND1 and MYC in the Wnt/β-Catenin signaling pathway, inhibited the tumor's occurrence, and inhibited the classical cancer pathway RTK pathway to inhibit cancer and improve OS.